Manulife US REIT will be included in the FTSE EPRA Nareit Global Developed Index, effective 23 December, the U.S. office REIT said in a filing to SGX Thursday.
“The inclusion of Manulife US REIT in the FTSE EPRA Nareit Index signifies higher trading liquidity and visibility to institutional investors and property funds, as well as a potential positive re-rating,” Jill Smith, CEO of the REIT’s manager, said in the statement.
“This will bolster our strong position as the U.S. REIT of choice as we continue to grow responsibly in 2020,” she added.
Smith noted that since the REIT’s listing on SGX 3.5 years ago, its market capitalization has tripled to US$1.5 billion, while building a diversified institutional investor base across Asia, Europe and the U.S.
The FTSE EPRA Nareit Global Developed Index tracks the performance of listed real estate companies and REITs globally.